Equities

Meso Numismatics Inc

MSSV:PKC

Meso Numismatics Inc

Actions
  • Price (USD)0.0363
  • Today's Change-0.009 / -20.31%
  • Shares traded10.21k
  • 1 Year change+187.78%
  • Beta1.3378
Data delayed at least 15 minutes, as of May 24 2024 15:23 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.

  • Revenue in USD (TTM)2.41m
  • Net income in USD-9.81m
  • Incorporated2001
  • Employees1.00
  • Location
    Meso Numismatics Inc433 Plaza Real Ste 275BOCA RATON 33432-3999United StatesUSA
  • Phone+1 (702) 483-0318
  • Fax+1 (509) 561-6923
  • Websitehttp://www.mesonumismatics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DMK Pharmaceuticals Corp3.62m-21.16m303.06k11.00------0.0837-8.69-9.181.04-0.49180.34325.665.54329,062.70-200.59-79.00---113.05-37.304.85-584.50-347.590.5355------115.34-18.3124.28---20.10--
CNBX Pharmaceuticals Inc540.25k-1.23m304.89k2.00------0.5644-0.0583-0.05830.0237-0.07581.73----270,125.00-393.70-73.32---99.806.37---228.08-3,970.88---1.37------111.900.3497------
Pure Harvest Corporate Group Inc2.48m-6.67m314.37k25.00--0.2071--0.1269-0.0901-0.09010.03830.02010.26441.4640.6499,070.40-70.96---136.76--33.83---268.37--0.5886-0.8660.7639--1,808.41---459.26------
Himalaya Technologies Inc0.00-629.85k335.46k2.00---------0.003-0.0030.00-0.0020.00-------270.93---------------------------193.23------
Cannabis Global, Inc.2.62m-3.16m373.18k3.00--0.0172--0.1425-0.0324-0.03240.0080.00580.192914.135.92---27.77-164.57-140.92---2.45---143.95-831.070.1799-1.750.3238--5,829.78---58.94------
Life Stem Genetics Inc0.00-568.02k393.34k1.00--0.21-----0.013-0.0130.000.00760.00----0.00-198.83---330.32--------------0.0241--------------
Better Therapeutics Inc0.00-31.57m403.88k54.00---------1.16-1.160.00-0.24490.00----0.00-162.15---378.28-------------15.183.27------1.43------
Baudax Bio Inc310.00k-25.83m435.93k9.00------1.41-17.25-9.170.0778-0.09850.0163----34,444.45-135.61-112.14---192.87-1,445.81---8,331.61-9,179.73----1.30--17.50---164.95---56.52--
Meso Numismatics Inc2.41m-9.81m453.03k1.00------0.188-0.7886-0.78860.1936-1.740.4398--65.37---179.09-192.08----69.5360.24-407.21-821.49---0.1103----57.49116.97-76.03--149.35--
Endonovo Therapeutics Inc255.72k-4.40m454.21k0.00------1.78-0.0652-0.06520.0003-0.0720.2256-------388.54-303.26----96.2174.38-1,722.26-5,956.27---1.38----85.15---495.02------
Pharmagreen Biotech Inc1.56k-500.66k530.92k0.00------340.33-0.0011-0.00110.00-0.00450.0094--3.35---302.10-472.20----11.54---32,096.15--0.0194-71.71--------80.68------
Hanyuan Biotech International Inc10.65m3.14m539.39k--0.02940.00640.14810.05060.22460.22460.76111.03----------------68.54--29.51--13.3625.660.00--50.51--106.71------
Molecular Pharmacology (USA) Ltd0.00-105.18k599.73k0.00---------0.0009-0.00090.00-0.01880.00-------976.60-1,219.29------------------------44.29------
Data as of May 24 2024. Currency figures normalised to Meso Numismatics Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.